Cryptococcal chest wall mass and rib osteomyelitis associated with the use of fingolimod: A case report and literature review
- PMID: 36160166
- PMCID: PMC9491343
- DOI: 10.3389/fmed.2022.942751
Cryptococcal chest wall mass and rib osteomyelitis associated with the use of fingolimod: A case report and literature review
Abstract
Being introduced in 2010, fingolimod was among the first oral therapies for relapsing multiple sclerosis (MS). Since that time, postmarketing surveillance has noted several case reports of various cryptococcal infections associated with fingolimod use. To date, approximately 15 such case reports have been published. We present the first and unique case of cryptococcal chest wall mass and rib osteomyelitis associated with fingolimod use. The patient presented with left-side chest pain and was found to have a lower left chest wall mass. Computerized tomography (CT) showed chest wall mass with the destruction of left 7th rib. Aspirate from the mass grew Cryptococcus neoformans. The isolate was serotype A. Fingolimod was stopped. The patient received liposomal amphotericin B for 2 weeks and started on fluconazole with a plan to continue for 6-12 months. The follow-up CT in 6 weeks showed a marked decrease in the size of the chest wall mass. In conclusion, our case highlights the atypical and aggressive form of cryptococcal infection possibly related to immunosuppression from fingolimod use.
Keywords: chest mass; cryptococcus; fingolimod; immunosuppression; osteomyelitis.
Copyright © 2022 Carpenter, Etemady-Deylamy, Costello, Khasawneh, Chamberland, Tian, Donlin, Moreira-Walsh, Reisenbichler and Abate.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Cerebral Venous Thrombosis due to Cryptococcus in a Multiple Sclerosis Patient on Fingolimod.Case Rep Neurol. 2022 Jun 24;14(2):286-290. doi: 10.1159/000524359. eCollection 2022 May-Aug. Case Rep Neurol. 2022. PMID: 35949205 Free PMC article.
-
Cryptococcal osteomyelitis of the Zygomatic bone: a case report.BMC Infect Dis. 2020 Jun 5;20(1):399. doi: 10.1186/s12879-020-05123-2. BMC Infect Dis. 2020. PMID: 32503446 Free PMC article.
-
Cryptococcal meningoencephalitis in an IgG2-deficient patient with multiple sclerosis on fingolimod therapy for more than five years - case report.BMC Neurol. 2020 Apr 27;20(1):158. doi: 10.1186/s12883-020-01741-0. BMC Neurol. 2020. PMID: 32340606 Free PMC article.
-
Cryptococcal rib osteomyelitis in a pediatric patient.J Pediatr Surg. 1998 May;33(5):771-3. doi: 10.1016/s0022-3468(98)90216-0. J Pediatr Surg. 1998. PMID: 9607497 Review.
-
Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.Mult Scler Relat Disord. 2016 Sep;9:158-62. doi: 10.1016/j.msard.2016.07.015. Epub 2016 Aug 4. Mult Scler Relat Disord. 2016. PMID: 27645366 Review.
Cited by
-
Isolated cryptococcal osteomyelitis of the sacrum in an immunocompetent patient: a case report and literature review.BMC Infect Dis. 2023 Feb 24;23(1):116. doi: 10.1186/s12879-023-08066-6. BMC Infect Dis. 2023. PMID: 36829132 Free PMC article. Review.
-
Cryptococcosis Associated With Biologic Therapy: A Narrative Review.Open Forum Infect Dis. 2024 Jun 26;11(7):ofae316. doi: 10.1093/ofid/ofae316. eCollection 2024 Jul. Open Forum Infect Dis. 2024. PMID: 38947739 Free PMC article. Review.
-
Cryptococcus neoformans osteomyelitis of the tibia: a case report and review of the literature.J Med Case Rep. 2023 May 7;17(1):188. doi: 10.1186/s13256-023-03925-x. J Med Case Rep. 2023. PMID: 37149631 Free PMC article. Review.
-
Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells.Cells. 2025 Apr 17;14(8):606. doi: 10.3390/cells14080606. Cells. 2025. PMID: 40277931 Free PMC article. Review.
-
Cryptococcus Neoformans Osteomyelitis of the Right Ankle Diagnosed by Metagenomic Next-Generation Sequencing in a HIV-Negative Patient with Tuberculous Lymphadenitis and Pulmonary Tuberculosis: A Case Report and Recent Literature Review.Infect Drug Resist. 2024 Sep 4;17:3805-3812. doi: 10.2147/IDR.S476270. eCollection 2024. Infect Drug Resist. 2024. PMID: 39253606 Free PMC article.
References
-
- Diniz-Lima IF, Silva LM, Guimarães-de-Oliveira EB, Freire-de-Lima JC, Nascimento L, Morrot DO, et al. . Cryptococcus: history, epidemiology, and immune evasion. App Sci. (2022) 12:7086. 10.3390/app12147086 - DOI
Publication types
LinkOut - more resources
Full Text Sources